
Updated Sunday 25 October 2026. IBM (NYSE: IBM) closed Friday 23 October at $253.56, up $1.45 or 0.58 percent, and was $253.00 after hours (StockAnalysis). The stock is 9.2 percent higher than a week ago and above the $251.46 it closed at on 21 October, the day it reported, even though it fell 5.11 percent after hours that night to $238.60 and opened the next session at $241.25 (Investing.com, StockAnalysis). The third quarter beat on every headline line: revenue $17.1 billion against $16.82 billion expected, operating EPS $2.95 against $2.86, software up 9 percent at constant currency, free cash flow $3.0 billion and the full-year free cash flow outlook raised to more than $1 billion of growth. What sold the stock was a revenue guide held at 4-5 percent, a quarter of the software growth coming from deals that slipped out of Q2, and chief executive Arvind Krishna saying large enterprises are asking "what is the true ROI of all of their AI spend". Verdict: a $253.56 close is just above the $250.45 200-day average and within 1.5 percent of the $257.22 consensus target, so this week the shares trade on the Fed and on what Microsoft, Alphabet and Amazon say about enterprise AI budgets rather than on IBM's own numbers. Reference levels: $240 below, $269 above.
The after-hours tape on 21 October looked like a verdict: down 5.11 percent to $238.60 on a beat. By 12:45 pm ET the next day the stock was $248.72 and by the close it was $252.11, 65 cents above where it had been before anyone saw the numbers, on the heaviest volume of the week. Friday added another 0.58 percent. So the week's story is not a sell-off but a repricing of what the beat was worth: enough to hold the $251 pre-print level, not enough to extend a run that had already taken the shares from $232.14 to $251.46 in the three sessions before the report. That matters for how to read the week ahead, because the stock now sits almost exactly on its 200-day average of $250.45 and within 1.5 percent of the Street's average target, with the 50-day at $233.04 well below. The easy move, the one from oversold to fair, is done.
Nine percent constant-currency software growth is the best print IBM has shown since the Q2 stumble, and the company raised the low end of its full-year software guide to 7 percent from 6 percent on the back of it. The debate is how much of it repeats. Kavanaugh's own split is that about three-quarters was net new business and a quarter was the Q2 slip deals; BofA puts the slip-deal catch-up at about $250 million, and UBS strips out both the catch-up and the acquired revenue from Confluent and HashiCorp to arrive at organic growth of about 1 percent. Transaction processing, the mainframe software line, grew 10 percent on z17 demand and Krishna himself expects "a moderation from 3Q going into the fourth quarter", with the line flat for the full year. Red Hat at 11 percent and Data at 20 percent are the parts that need no asterisk, and OpenShift ARR growing more than 30 percent is the number the bulls will quote. UBS adds the 2027 problem: Confluent's contribution laps in March 2027, after which software growth could fall below the roughly 7.5 percent the Street has pencilled in, and management has said only that it will quantify 2027 in January.
Consulting was flat as reported, up 2 percent in constant currency, with margin down 60 basis points to 12.2 percent and a quarterly book-to-bill below 1. AI is now 30 percent of consulting revenue and 35 percent of backlog, which is the point: IBM's consulting arm is the part of the company most exposed to the budgets Krishna described when Jefferies' Brent Thill asked about demand. His answer, that the largest enterprises are focused on "what is the true ROI of all of their AI spend" and that some worry spending is "completely out of control with no real return", is the same message that has weighed on Palantir since Gartner's forward-deployed-AI warning. It is also why this week's calendar matters more to IBM than usual: Microsoft and Alphabet report after Wednesday's close and Amazon after Thursday's, and their cloud growth and capex lines are the clearest read the market gets on whether enterprise AI budgets are being cut or merely scrutinised. Our Amazon page sets out what AWS needs to show.
| Scenario | Level | What has to happen | Anchor |
|---|---|---|---|
| Bear | $240 | Microsoft, Alphabet or Amazon flag slower enterprise AI spending or guide capex in a way that reprices the whole group, a hawkish Warsh press conference lifts the 10-year back toward 5 percent, and the shares give back the post-results recovery. | The $240.00 intraday low of 22 October, the session the after-hours drop was bought; also just below UBS's $243 Neutral target. About 5.3 percent below Friday's close and below the 200-day average. |
| Base | $248-$258 | The megacap prints confirm cloud demand without changing the AI-budget debate, the Fed holds as priced, and IBM trades around its 200-day average and the consensus target while the software-sustainability argument is unresolved. | Friday's $253.56 plus or minus about 2 percent, bracketing the $250.45 200-day average and the $257.22 average target (StockAnalysis). |
| Bull | $269 | Azure, Google Cloud and AWS growth re-accelerate and capex guides are taken as demand rather than excess, the 10-year eases after the Fed, and the Buy-rated houses' targets pull the stock through the median $260. | JPMorgan's $269 Overweight target, just under RBC's $270 and Goldman's path to $300; about 6.1 percent above Friday's close. |
The bear case sits below Friday's price. These are reference levels measured from the verified quotes and published targets, not forecasts.
Quick take: IBM goes into Fed week at $253.56, up 9.2 percent in five sessions, after a Q3 beat whose after-hours sell-off was fully bought back within a day. The shares sit on the 200-day average and within 1.5 percent of the Street's target, so the next move comes from Microsoft, Alphabet and Amazon's read on enterprise AI budgets and from Wednesday's Fed. Strong cloud prints and a calm Warsh open $269; an AI-budget warning or a hawkish Fed opens $240.
IBM closed at $253.56 on Friday 23 October 2026, up 0.58 percent, and was $253.00 after hours (StockAnalysis). Markets are closed on Sunday 25 October.
Yes. Revenue was $17.1 billion against $16.82 billion expected and operating EPS $2.95 against $2.86. Software grew 9 percent at constant currency, free cash flow was $3.0 billion and the full-year free cash flow outlook was raised (IBM 8-K, Investing.com).
The shares fell 5.11 percent after hours on 21 October because the full-year revenue guide was held at 4-5 percent, about a quarter of the software growth came from deals delayed out of Q2, and Krishna described enterprises scrutinising the return on AI spending. The drop was bought the next day and the stock closed higher than before the report (Investing.com, StockAnalysis).
The StockAnalysis average is $257.22 across 25 analysts, median $260, with a $174-$300 range. After the print Goldman Sachs went to $300, Jefferies $280, RBC $270, JPMorgan $269, BMO $265, Truist, Stifel and Baird $260, Susquehanna $256 and UBS $243.
Management guides 7-8 percent for the year. About a quarter of Q3's growth came from slipped Q2 deals, UBS estimates organic growth near 1 percent excluding that and acquisitions, and transaction processing is expected to moderate in Q4. Red Hat at 11 percent and Data at 20 percent are the organic drivers (earnings call, Investing.com).
$6.76 a year, or $1.69 a quarter, for a 2.67 percent yield at Friday's close. The next ex-dividend date shown is 10 November 2026 (StockAnalysis).
Q4 and full-year 2026 results are tentatively scheduled for 27 January 2027, when management has said it will quantify its 2027 outlook. Consensus is $4.62 of EPS on $20.47 billion of revenue (Investing.com).
Sources: StockAnalysis (closing, after-hours and daily history prices 16-23 October 2026, statistics, analyst consensus and target changes); IBM Form 8-K exhibit 99.1 (Q3 2026 results and outlook, 21 October); Investing.com (Q3 slides summary and after-hours move, 21 October; earnings analysis by Luke Juricic with UBS, BofA, Bernstein and consensus figures, 22 October); Motley Fool (Q3 2026 earnings call transcript: Krishna and Kavanaugh quotes); GuruFocus, MarketBeat and ad-hoc-news (Stifel, Baird, Susquehanna, JPMorgan, Jefferies and Morgan Stanley target changes, 15-22 October); CME FedWatch and Reuters poll (Fed probabilities, 24-25 October); Seeking Alpha, TradingKey and FXEmpire (week-ahead calendar: Fed, Microsoft, Alphabet, Amazon, GDP, PCE).
Disclaimer: This article is for informational purposes only and does not constitute financial or investment advice. Stocks are volatile and you can lose money. Do your own research and consult a licensed financial adviser before making investment decisions.